Thalassemias & Hemoglobinopathies Bio-Rad is committed to the prevention, diagnosis, and treatment of hemoglobinopathies.

As part of Bio-Rad’s continuing commitment, we strive to share experience and knowledge of the global health care community.  We have selected a number of informative articles written by esteemed members of the Hemoglobinopathy Community to help further your understanding of these conditions.

Please select one of the articles to the right of the screen to begin reading.

What are Hemoglobinopathies?

Hemoglobinopathies are a group of inherited conditions in which there are abnormalities in the structure (sickle cell disorders) or the quantity (thalassemia) of hemoglobin produced.  While more than 900 hemoglobin variants have been identified, only a subset of these mutations are considered clinically significant.

Global Distribution of Pathological Hemoglobin Disorders

Approximately 7% of the World's population is a carrier for hemoglobin disorders, and between 300.000 and 500.000 infants with the severe forms of this disease are born each year. — World Bank, 2006.